<?xml version="1.0" encoding="UTF-8"?>
<p>Nerol (30 to 300 mg/kg) prevented or decreased the pathological changes observed in the colitis model. It also showed antinociceptive effects and reduced the increased levels of inflammatory cytokines (IL-13 and TNF-α) [
 <xref rid="B91-molecules-25-05430" ref-type="bibr">91</xref>]. Among the inflammatory cytokines, TNF-α secreted by several populations of immune and stromal cells is considered responsible for amplifying and maintaining chronic inflammation in IBDs [
 <xref rid="B3-molecules-25-05430" ref-type="bibr">3</xref>]; its inhibition has been used as a therapeutic strategy in IBDs [
 <xref rid="B15-molecules-25-05430" ref-type="bibr">15</xref>].
</p>
